Clincosm LogoSign in Get a demo

Hemoglobinopathies

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases Trial in Nanning (RM-004)

Recruiting
  • Alpha Thalassemia Hemoglobin H Constant Spring
  • +2 more
  • RM-004
  • Nanning, Guangxi, China
    The 923rd Hospital of Joint Logistics Support Force of People's
Oct 25, 2023

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Recruiting
  • Sickle Cell Disease
  • +3 more
  • GWAS
  • Boston, Massachusetts
  • +24 more
Apr 4, 2023

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

Recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Nashville, Tennessee
  • +5 more
Feb 2, 2023

Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)

Recruiting
  • Sickle Cell Disease
  • +4 more
  • CTX001
  • Philadelphia, Pennsylvania
  • +3 more
Jan 24, 2023

Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)

Recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • EDIT-301
  • Oakland, California
  • +18 more
Jan 10, 2023

Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

Recruiting
  • Transfusion Dependent Beta Thalassemia
  • +3 more
  • EDIT-301
  • Oakland, California
  • +3 more
Jan 3, 2023

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia, Hemoglobinopathies Trial in San Francisco (in utero hematopoietic

Enrolling by invitation
  • Alpha Thalassemia Major
  • +8 more
  • in utero hematopoietic stem cell transplantation
  • San Francisco, California
    University of California
Oct 28, 2022

Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

Not yet recruiting
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • (no location specified)
Jul 26, 2022

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)

Completed
  • Hemoglobinopathies
  • +3 more
  • Hemoglobinopathy Nursing Program
  • Banhā, Other, Egypt
    Benha University
May 21, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

Recruiting
  • Non Malignant Diseases
  • +2 more
  • RIC: Distal Campath
  • +2 more
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 8, 2022

Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

Active, not recruiting
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Feb 28, 2022

Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

Recruiting
  • Severe Sickle Cell Disease
  • +5 more
  • RIC regimen
  • GVHD prophylaxis regimen
  • New Haven, Connecticut
  • +1 more
Feb 4, 2022

Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

Active, not recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Dec 20, 2021

Screening for Hemoglobinopathies in Pregnant Women

Recruiting
  • Hemoglobinopathies
  • Review of routine lab data
  • Basel, Switzerland
    Frauenklinik University Hospital Basel
Oct 13, 2021

Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies Trial in Canada, United States (Treatment

Recruiting
  • Metabolic Disorders
  • +3 more
  • Treatment Plan 1: Stratum 1
  • +3 more
  • Phoenix, Arizona
  • +19 more
Oct 12, 2021

Clofarabine and Fludarabine Drug Exposure in Pediatric Bone

Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell

Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Fludarabine Drug Exposure in Pediatric Bone Marrow

Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Hematologic Disorders, Hemoglobinopathies, Immunodeficiencies Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Hematologic Disorders
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jul 12, 2021

Hemoglobinopathies Trial (transcranial doppler)

Not yet recruiting
  • Hemoglobinopathies
  • transcranial doppler
  • (no location specified)
Mar 12, 2021